Headline
The latest stories from AHA Today.
Leon Caldwell, AHA senior director of health equity strategies and innovation, talks with James Min, M.D., CEO and co-founder of Cleerly, and Richard Chazal, M.D., senior cardiologist and medical director at Lee Health System’s Heart & Vascular Institute, about their transformative approach to…
The Department of Health and Human Services yesterday launched “I am a Work of ART,” a national campaign to encourage people with HIV to seek or continue care and antiretroviral therapy, part of the national strategy to end the HIV epidemic by 2030.
The Food and Drug Administration today authorized Moderna’s COVID-19 vaccine for children aged 6 months through 17 years old and Pfizer’s COVID-19 vaccine for children aged 6 months through 4 years old, as recommended this week by its vaccine advisory committee.
A new special issue of Health Services Research focuses on how health care organizations can use implementation science and community-engaged research methods to improve population health and reduce care disparities.
“Understanding potential costs is an important part of the patient experience when planning for care, and hospitals and health systems are committed to helping patients navigate that process,” writes Ari Levin, AHA’s director of coverage policy.
The Centers for Medicare & Medicaid Services today approved state plan amendments allowing Maine, Minnesota, New Mexico and Washington, D.C., to extend postpartum coverage from 60 days to 12 months after pregnancy for Medicaid and Children’s Health Insurance Program enrollees under the American…
COVID-19 hospitalization rates are about 50% higher for adults eligible for Medicare because of a disability than for other adults enrolled in Medicare.
President Biden yesterday directed the Health and Human Services Secretary to develop and release sample policies for states “to safeguard and expand access to health care for LGBTQI+ individuals and their families, including mental health services.”
A Food and Drug Administration advisory committee today recommended the agency authorize Moderna’s COVID-19 two-dose vaccine for children aged 6 months through 5 years old and Pfizer’s three-dose COVID-19 vaccine for children aged 6 months through 4 years old
The National Center for Healthcare Leadership is accepting nominations through July 8 for the 2022 Gail L. Warden Leadership Excellence Award.